RECURRENT MEDULLOBLASTOMA
Clinical trials for RECURRENT MEDULLOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MEDULLOBLASTOMA trials appear
Sign up with your email to follow new studies for RECURRENT MEDULLOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a Virus-Fighting vaccine shrink deadly childhood brain tumors?
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a vaccine called PEP-CMV in 120 children and young adults with aggressive brain tumors (high-grade glioma, DIPG, or recurrent medulloblastoma). The vaccine targets a protein from a common virus (CMV) that often hides in these tumors, aiming to train the immune sy…
Matched conditions: RECURRENT MEDULLOBLASTOMA
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 13:54 UTC
-
RNA vaccine trial offers new hope for kids with recurrent brain cancer
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a personalized RNA vaccine for children and young adults (ages 3–39) whose medulloblastoma has returned after standard treatment. The vaccine is made from the patient's own tumor and aims to train the immune system to fight the cancer. The main goals are to see i…
Matched conditions: RECURRENT MEDULLOBLASTOMA
Phase: PHASE1 • Sponsor: University of Florida • Aim: ⭐️ VACCINE ⭐️
Last updated May 13, 2026 16:02 UTC
-
Engineered immune cells target deadly childhood brain tumors
Disease control Recruiting nowThis early-phase trial tests a new treatment for children and young adults with medulloblastoma or other rare brain tumors that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified to recognize and attack a protein calle…
Matched conditions: RECURRENT MEDULLOBLASTOMA
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 26, 2026 10:30 UTC
-
New hope for kids with tough brain tumors: targeted radiation drug enters trial
Disease control Recruiting nowThis study tests a drug called Lutathera in children and young adults (ages 4 to 39) whose brain tumors have come back or are growing despite treatment. The drug delivers radiation directly to tumor cells that show up on a special PET scan. The goal is to find the safest dose and…
Matched conditions: RECURRENT MEDULLOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated May 26, 2026 10:29 UTC